Literature DB >> 12480557

Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease.

Yoshio Sumida1, Toshiaki Nakashima, Takaharu Yoh, Masanori Furutani, Akihisa Hirohama, Yuko Kakisaka, Yoshiki Nakajima, Hiroki Ishikawa, Hironori Mitsuyoshi, Takeshi Okanoue, Kei Kashima, Hajime Nakamura, Junji Yodoi.   

Abstract

BACKGROUND/AIMS: Thioredoxin (TRX) is a stress-inducible thiol-containing protein. The aim of this study was to evaluate the clinical significance of serum TRX in patients with nonalcoholic steatohepatitis (NASH) or simple steatosis.
METHODS: Serum TRX levels were determined using an enzyme-linked immunosorbent assay kit in 25 patients with NASH, 15 patients with simple steatosis, and 17 healthy volunteers.
RESULTS: Serum TRX levels (medians and (ranges), ng/ml) were significantly elevated in patients with NASH (60.3 (17.6-104.7)), compared to those in patients with simple steatosis (24.6 (16.6-69.7), P=0.0009) and in healthy controls (23.5 (1.3-50.7), P<0.0001). Serum ferritin levels in patients with NASH were also significantly higher than the levels in patients with simple steatosis. The receiver operating characteristic curve confirmed that serum TRX and ferritin levels were predictors for distinguishing NASH from simple steatosis. Higher grades of histological iron staining were observed in NASH than in simple steatosis. Serum TRX tended to increase in accordance with hepatic iron accumulation and the histological severity in patients with NASH.
CONCLUSIONS: The pathogenesis of NASH may be associated with iron-related oxidative stress. The serum TRX level is a parameter for discriminating NASH from simple steatosis as well as a predictor of the severity of NASH.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12480557     DOI: 10.1016/s0168-8278(02)00331-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  52 in total

1.  Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.

Authors:  James E Nelson; Laura Wilson; Elizabeth M Brunt; Matthew M Yeh; David E Kleiner; Aynur Unalp-Arida; Kris V Kowdley
Journal:  Hepatology       Date:  2010-11-29       Impact factor: 17.425

Review 2.  Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis.

Authors:  Diana L Diesen; Paul C Kuo
Journal:  J Surg Res       Date:  2009-10-09       Impact factor: 2.192

Review 3.  Clinical implications of oxidative stress and antioxidant therapy.

Authors:  Gerald W Dryden; Ion Deaciuc; Gavin Arteel; Craig J McClain
Journal:  Curr Gastroenterol Rep       Date:  2005-08

4.  Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.

Authors:  Ali Afsari; Edward Lee; Babak Shokrani; Tina Boortalary; Zaki A Sherif; Mehdi Nouraie; Adeyinka O Laiyemo; Kawtar Alkhalloufi; Hassan Brim; Hassan Ashktorab
Journal:  Dig Dis Sci       Date:  2017-06-13       Impact factor: 3.199

5.  The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease.

Authors:  Yuichiro Eguchi; Toshihiko Mizuta; Yoshio Sumida; Eriko Ishibashi; Yoichiro Kitajima; Hiroshi Isoda; Hiroko Horie; Takaya Tashiro; Eri Iwamoto; Hirokazu Takahashi; Takuya Kuwashiro; Shu Soejima; Yasunori Kawaguchi; Yasutomo Oda; Sei Emura; Ryuichi Iwakiri; Iwata Ozaki; Takahisa Eguchi; Naofumi Ono; Keizo Anzai; Kazuma Fujimoto; Shunzo Koizumi
Journal:  J Gastroenterol       Date:  2010-11-02       Impact factor: 7.527

6.  Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and Treatment.

Authors:  Joel Z Stengel; Stephen A Harrison
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-06

7.  Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis.

Authors:  Kosuke Okada; Eiji Warabi; Hirokazu Sugimoto; Masaki Horie; Katsutoshi Tokushige; Tetsuya Ueda; Nobuhiko Harada; Keiko Taguchi; Etsuko Hashimoto; Ken Itoh; Tetsuro Ishii; Hirotoshi Utsunomiya; Masayuki Yamamoto; Junichi Shoda
Journal:  J Gastroenterol       Date:  2012-02-28       Impact factor: 7.527

Review 8.  Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-13       Impact factor: 3.199

9.  Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.

Authors:  Anil Arora; Praveen Sharma
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

10.  Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate.

Authors:  Shoko Tsuchikura; Tetsuo Shoji; Naoko Shimomura; Ryusuke Kakiya; Masanori Emoto; Hidenori Koyama; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa
Journal:  BMC Nephrol       Date:  2010-04-27       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.